Prediction and associations of preterm birth and its subtypes with eicosanoid enzymatic pathways and inflammatory markers
暂无分享,去创建一个
Youfei Yu | Bhramar Mukherjee | Subramaniam Pennathur | Max T. Aung | John D. Meeker | Kelly K. Ferguson | Thomas F. McElrath | J. Meeker | B. Mukherjee | S. Pennathur | K. Ferguson | T. McElrath | D. Cantonwine | M. Aung | L. Zeng | David E. Cantonwine | Lixia Zeng | Youfei Yu
[1] G. Rao,et al. Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies. , 2019, Progress in lipid research.
[2] Nitesh V. Chawla,et al. SMOTE: Synthetic Minority Over-sampling Technique , 2002, J. Artif. Intell. Res..
[3] R. T. Lie,et al. Long-Term Medical and Social Consequences of Preterm Birth , 2009 .
[4] K. Vaswani,et al. Review: Eicosanoids in preterm labor and delivery: Potential roles of exosomes in eicosanoid functions. , 2017, Placenta.
[5] M. Klebanoff,et al. Epidemiology: the changing face of preterm birth. , 2011, Clinics in perinatology.
[6] X. Zhan,et al. Association between the maternal serum levels of 19 eicosanoids and pre‐eclampsia , 2016, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[7] H. Zou,et al. An Efficient Algorithm for Computing the HHSVM and Its Generalizations , 2013 .
[8] B. Levy,et al. Resolvins and protectins: mediating solutions to inflammation , 2009, British journal of pharmacology.
[9] S. Lye,et al. Prostaglandins and mechanisms of preterm birth. , 2002, Reproduction.
[10] C. Redman,et al. The role of angiogenic factors in the management of preeclampsia , 2019, Acta obstetricia et gynecologica Scandinavica.
[11] G. Wallukat,et al. Cytochrome P450 Subfamily 2J Polypeptide 2 Expression and Circulating Epoxyeicosatrienoic Metabolites in Preeclampsia , 2012, Circulation.
[12] D. MacIntyre,et al. Anti-inflammatory prostaglandins for the prevention of preterm labour. , 2014, Reproduction.
[13] Noah Simon,et al. A Sparse-Group Lasso , 2013 .
[14] J. Rokach,et al. Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid. , 2015, Biochimica et biophysica acta.
[15] P. Maloberti,et al. Expression and function of OXE receptor, an eicosanoid receptor, in steroidogenic cells , 2013, Molecular and Cellular Endocrinology.
[16] J. Rokach,et al. 5-Oxo-ETE and the OXE receptor. , 2009, Prostaglandins & other lipid mediators.
[17] R. Tibshirani. Regression Shrinkage and Selection via the Lasso , 1996 .
[18] F. L. Borgne,et al. Biosynthesis, metabolism and function of protectins and resolvins , 2014 .
[19] D. Tousoulis,et al. The Role of Oxidative Stress , 2018 .
[20] D. Barrett,et al. Measurement of vasoactive metabolites (hydroxyeicosatetraenoic and epoxyeicosatrienoic acids) in uterine tissues of normal and compromised human pregnancy , 2010, Journal of hypertension.
[21] N. Patel,et al. Reduction of renal ischemia-reperfusion injury in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton. , 2004, Molecular pharmacology.
[22] L. Goldsmith,et al. The maternal immune system during pregnancy and its influence on fetal development , 2015 .
[23] M. Iadarola,et al. Lipidomic profiling of targeted oxylipins with ultra-performance liquid chromatography-tandem mass spectrometry , 2018, Analytical and Bioanalytical Chemistry.
[24] T. Nawrot,et al. Cord blood eicosanoid signatures and newborn gestational age. , 2017, Prostaglandins & other lipid mediators.
[25] Bhramar Mukherjee,et al. Repeated measures of urinary oxidative stress biomarkers during pregnancy and preterm birth. , 2015, American journal of obstetrics and gynecology.
[26] M. Merialdi,et al. The Changing Face of Preterm Birth , 2007, Pediatrics.
[27] S. Swan,et al. Urinary oxidative stress biomarkers and accelerated time to spontaneous delivery , 2019, Free radical biology & medicine.
[28] J. Falck,et al. Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertension-induced end-organ damage in Ren-2 transgenic rats. , 2010, Clinical science.
[29] G. Zanconato,et al. Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta , 2016, Journal of hypertension.
[30] W. Callaghan,et al. The Contribution of Preterm Birth to Infant Mortality Rates in the United States , 2006, Pediatrics.
[31] Xiang Fang,et al. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. , 2004, Progress in lipid research.
[32] J. Morrison,et al. Preterm birth. , 2002, Clinical evidence.
[33] M. Mathias,et al. Prostaglandins in selected reproductive tissues in preterm and full-term gestations. , 1996, Prostaglandins, leukotrienes, and essential fatty acids.
[34] C. Prada,et al. Endothelial dysfunction and preeclampsia: role of oxidative stress , 2014, Front. Physiol..
[35] Samuel Parry,et al. Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy. , 2012, American journal of obstetrics and gynecology.
[36] R. Browne,et al. Analytical and biological variation of biomarkers of oxidative stress during the menstrual cycle , 2008, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[37] Garret A. FitzGerald,et al. Prostaglandins and Inflammation , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[38] J. Meeker,et al. Longitudinal Profiling of Inflammatory Cytokines and C‐reactive Protein during Uncomplicated and Preterm Pregnancy , 2014, American journal of reproductive immunology.
[39] J. Mcgregor,et al. Maternal and perinatal long-chain fatty acids: possible roles in preterm birth. , 1997, American journal of obstetrics and gynecology.
[40] A. Leviton,et al. American Journal of Epidemiology Original Contribution Pregnancy Disorders That Lead to Delivery before the 28th Week of Gestation: an Epidemiologic Approach to Classification , 2022 .
[41] J. Mcgiff,et al. Maternal and fetal epoxyeicosatrienoic acids in normotensive and preeclamptic pregnancies. , 2013, American journal of hypertension.
[42] G. Michailidis,et al. Elevated lipoxygenase and cytochrome P450 products predict progression of chronic kidney disease. , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[43] K. Wallace,et al. Arachidonic acid metabolites of CYP4A and CYP4F are altered in women with preeclampsia. , 2018, Prostaglandins & other lipid mediators.
[44] S. Dar,et al. Inflammatory-mediated pathway in association with organochlorine pesticides levels in the etiology of idiopathic preterm birth. , 2015, Reproductive toxicology.
[45] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[46] J. Meeker,et al. Urinary Polycyclic Aromatic Hydrocarbon Metabolite Associations with Biomarkers of Inflammation, Angiogenesis, and Oxidative Stress in Pregnant Women. , 2017, Environmental science & technology.
[47] É. Rousseau,et al. Effect of cytochrome P‐450 epoxygenase and hydroxylase metabolites on rat myometrium contractility in non‐pregnancy, late pregnancy and late pregnancy under inflammatory conditions , 2014, The journal of obstetrics and gynaecology research.
[48] Hao Helen Zhang,et al. ON THE ADAPTIVE ELASTIC-NET WITH A DIVERGING NUMBER OF PARAMETERS. , 2009, Annals of statistics.
[49] A. E. Hoerl,et al. Ridge Regression: Applications to Nonorthogonal Problems , 1970 .
[50] A. E. Hoerl,et al. Ridge regression: biased estimation for nonorthogonal problems , 2000 .
[51] G. Wallukat,et al. CYP2J2 Expression and Circulating Epoxyeicosatrienoic Metabolites in Preeclampsia , 2012 .
[52] J. Meeker,et al. Variability in urinary phthalate metabolite levels across pregnancy and sensitive windows of exposure for the risk of preterm birth. , 2014, Environment international.
[53] A. Kannan,et al. A Novel Pathway Involving Progesterone Receptor, 12/15-Lipoxygenase-derived Eicosanoids, and Peroxisome Proliferator-activated Receptor γ Regulates Implantation in Mice* , 2004, Journal of Biological Chemistry.